Y. Miyazaki

1.8k total citations
17 papers, 1.5k citations indexed

About

Y. Miyazaki is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Y. Miyazaki has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Y. Miyazaki's work include Metabolism, Diabetes, and Cancer (8 papers), Diet and metabolism studies (5 papers) and Diabetes and associated disorders (3 papers). Y. Miyazaki is often cited by papers focused on Metabolism, Diabetes, and Cancer (8 papers), Diet and metabolism studies (5 papers) and Diabetes and associated disorders (3 papers). Y. Miyazaki collaborates with scholars based in United States, Japan and Italy. Y. Miyazaki's co-authors include Ralph A. DeFronzo, Masafumi Matsuda, Amalia Gastaldelli, Ele Ferrannini, Lawrence J. Mandarino, Archana Mahankali, Curtis Triplitt, Ruben Pipek, Kenneth Cusi and Leonard C. Glass and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Kidney International.

In The Last Decade

Y. Miyazaki

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Miyazaki United States 15 833 695 386 333 301 17 1.5k
Yasumichi Mori Japan 18 584 0.7× 901 1.3× 485 1.3× 404 1.2× 303 1.0× 50 1.8k
J A Scarlett United States 9 809 1.0× 618 0.9× 551 1.4× 439 1.3× 172 0.6× 13 1.5k
Yuji Tajiri Japan 17 414 0.5× 329 0.5× 325 0.8× 296 0.9× 233 0.8× 73 1.1k
Stephen J. Cleland United Kingdom 22 785 0.9× 318 0.5× 477 1.2× 336 1.0× 369 1.2× 37 1.7k
J Insel United States 7 594 0.7× 497 0.7× 594 1.5× 335 1.0× 160 0.5× 8 1.3k
Hanne L. Gulseth Norway 17 636 0.8× 354 0.5× 463 1.2× 420 1.3× 231 0.8× 31 1.4k
Hideyuki Eguchi Japan 9 896 1.1× 353 0.5× 225 0.6× 168 0.5× 203 0.7× 17 1.3k
Maura Pettiti Italy 11 727 0.9× 577 0.8× 594 1.5× 349 1.0× 644 2.1× 11 1.5k
Toshihide Oizumi Japan 23 361 0.4× 342 0.5× 302 0.8× 163 0.5× 393 1.3× 43 1.5k
Dominik Dahl Germany 15 679 0.8× 382 0.5× 636 1.6× 257 0.8× 214 0.7× 26 1.4k

Countries citing papers authored by Y. Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Y. Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Miyazaki more than expected).

Fields of papers citing papers by Y. Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Miyazaki. The network helps show where Y. Miyazaki may publish in the future.

Co-authorship network of co-authors of Y. Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Miyazaki. A scholar is included among the top collaborators of Y. Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Miyazaki. Y. Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Saitoh, Shigeyuki, Hirofumi Ohnishi, Hiroshi Akasaka, et al.. (2011). Matsuda–DeFronzo insulin sensitivity index is a better predictor than HOMA-IR of hypertension in Japanese: the Tanno–Sobetsu study. Journal of Human Hypertension. 26(5). 325–333. 21 indexed citations
2.
Miyazaki, Y. & Ralph A. DeFronzo. (2008). Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Diabetes Obesity and Metabolism. 10(12). 1204–1211. 79 indexed citations
3.
Berria, Rachele, Leonard C. Glass, Archana Mahankali, et al.. (2007). Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus. Clinical Pharmacology & Therapeutics. 82(3). 275–281. 70 indexed citations
4.
Miyazaki, Y., Eugênio Cersósimo, Curtis Triplitt, & Ralph A. DeFronzo. (2007). Rosiglitazone decreases albuminuria in type 2 diabetic patients. Kidney International. 72(11). 1367–1373. 92 indexed citations
5.
Gastaldelli, Amalia, Ele Ferrannini, Y. Miyazaki, Masafumi Matsuda, & Ralph A. DeFronzo. (2004). Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia. 47(1). 31–39. 259 indexed citations
6.
Gastaldelli, Amalia, Ele Ferrannini, Y. Miyazaki, Masafumi Matsuda, & Ralph A. DeFronzo. (2004). Reply to Comment on: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 43:31?39. Diabetologia. 47(9). 1643–1644. 42 indexed citations
7.
Miyazaki, Y., Ruben Pipek, Lawrence J. Mandarino, & Ralph A. DeFronzo. (2003). Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients. International Journal of Obesity. 27(1). 88–94. 122 indexed citations
8.
Ferrannini, Ele, Amalia Gastaldelli, Y. Miyazaki, et al.. (2003). Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia. 46(9). 1211–1219. 98 indexed citations
9.
Miyazaki, Y.. (2002). Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2784–2791. 117 indexed citations
10.
Miyazaki, Y., Leonard C. Glass, Curtis Triplitt, et al.. (2001). Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients. Diabetologia. 44(12). 2210–2219. 231 indexed citations
11.
Pijl, Hanno, Satoru Ohashi, Masafumi Matsuda, et al.. (2000). Bromocriptine: a novel approach to the treatment of type 2 diabetes.. Diabetes Care. 23(8). 1154–1161. 184 indexed citations
12.
Higashiura, Katsuhiro, N Ura, Y. Miyazaki, & Kazuaki Shimamoto. (1999). Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension. Journal of Human Hypertension. 13(S1). S71–S74. 45 indexed citations
13.
Miyazaki, Y., Hideyuki Murakami, Jun Agata, et al.. (1998). Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives. American Journal of Hypertension. 11(9). 1056–1064. 6 indexed citations
14.
Shimamoto, Kazuaki, N Ura, Katsuhiro Higashiura, et al.. (1996). The Mechanisms of the Improvement of Insulin Sensitivity by Angiotensin Converting Enzyme Inhibitor. Clinical and Experimental Hypertension. 18(2). 257–266. 14 indexed citations
15.
Miyazaki, Y., et al.. (1996). EFFECTS OF HYPERINSULINAEMIA ON RENAL FUNCTION AND THE PRESSOR SYSTEM IN INSULIN‐RESISTANT OBESE ADOLESCENTS. Clinical and Experimental Pharmacology and Physiology. 23(4). 287–290. 6 indexed citations
16.
Shimamoto, Kazuaki, Ise T, Y. Miyazaki, et al.. (1994). Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?. PubMed. 8(10). 755–9. 47 indexed citations
17.
Kim, Hyungjun, Hiroaki Kadowaki, H Sakura, et al.. (1992). Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms. Diabetologia. 35(3). 261–266. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasumichi Mori Breakdown of academic impact, for papers by J A Scarlett Breakdown of academic impact, for papers by Yuji Tajiri Breakdown of academic impact, for papers by Stephen J. Cleland Breakdown of academic impact, for papers by J Insel Breakdown of academic impact, for papers by Hanne L. Gulseth Breakdown of academic impact, for papers by Hideyuki Eguchi Breakdown of academic impact, for papers by Maura Pettiti Breakdown of academic impact, for papers by Toshihide Oizumi Breakdown of academic impact, for papers by Dominik Dahl
Rankless by CCL
2026